Personalized anti-cancer agent screening system

作者: Kyeung Min Joo , Do Hyun Nam

DOI:

关键词:

摘要: The present invention relates to a system for screening personalized anticancer agents, method agents using the system, and an apparatus agents. When inventive is used, agent showing optimal activity against cancer cells collected from patient can be selected variety of it possible previously examine therapeutic response that appear when administered into patient. Thus, risk trial error in therapy reduced, cost time required reduced.

参考文章(14)
Doug Dolginow, Vern Norviel, Dietrich Stephan, Janet Warrington, Methods for stratifying and annotating cancer drug treatment options ,(2009)
Hidetaka Kobayashi, Takumi Kawabe, Sensitivity test to predict efficacy of anti-cancer therapies ,(2004)
Aaron K. Chamberlain, John R. Desjarlais, Maria D. Barbosa, Optimized proteins that target ep-cam ,(2006)
Shin-ichi Yaguchi, Yasuhisa Fukui, Ichiro Koshimizu, Hisashi Yoshimi, Toshiyuki Matsuno, Hiroaki Gouda, Shuichi Hirono, Kanami Yamazaki, Takao Yamori, Antitumor Activity of ZSTK474, a New Phosphatidylinositol 3-Kinase Inhibitor Journal of the National Cancer Institute. ,vol. 98, pp. 545- 556 ,(2006) , 10.1093/JNCI/DJJ133
Alberto Orfao, Lilia Suarez, Juan Ballesteros, Maria Matoses, Consuelo Tudela, Teresa Bennett, Andrew Bosanquet, Daniel Primo, Santiago Lago, Coyt Jackson, Pilar Hernandez, Julian Gorrochategui, Luis Ignacio Caveda, Sandra Sapia, Methods for providing personalized medicine tests ex vivo for hematological neoplasms ,(2010)